stars 1 stars 2 stars 3

The Filariasis Research Reagent Resource Center (FR3) has provided a central resource of filariasis reagents, protocols and technical support for the international NTD research community since 1969. Supported by the National Institute of Allergy and Infectious Diseases (NIAID), the FR3 acquires and distributes parasites, vectors, and molecular and serological reagents. The FR3 is is funded by the Animal Models of Infectious Disease contract mechanism, which also funds the malaria ( MR4) and schistosomiasis (SR3) repositories. The FR3 is based at the University of Georgia College of Veterinary Medicine , where Dr. Andy Moorhead is the director and primary investigator. The University of Georgia subcontracts with Smith College (Dr. Steven Williams) for molecular resource development and production, and with University of Wisconsin-Oshkosh (Dr. Shelly Michalski) to maintain the filarial parasite Acanthocheilonema viteae, as well as to manage informational resources.

Fr3 Questions

The Fr3 annual revenue was $6 million in 2026.

1 people are employed at Fr3.

Fr3 is based in Bethesda, Maryland.

The NAICS codes for Fr3 are [54, 541714, 541, 5417, 54171].

The SIC codes for Fr3 are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users